Healthy Clinical Trial
— GatekeeperOfficial title:
Healthy Lifestyle Habits Promotion to Improve Elderly People Health
The GATEKEEPER project, funded by the European Commission's HORIZON 2020 innovation framework, aims to ensure healthier independent living for ageing populations. To this end, GATEKEEPER aims to develop an open, European-wide, standards-based, interoperable and secure platform, available to all stakeholders (healthcare professionals, technology companies and users), offering digital solutions on the Internet of Things, Big Data or Artificial Intelligence, or new techniques, for early detection and personalised interventions to ensure healthier independent living for ageing populations. GATEKEEPER will demonstrate its value by scaling up innovative solutions, during a 48-month work plan that will involve 40.000 elderly citizens, as well as authorities, institutions, companies, associations and academic centres from 8 pilot regions in 7 EU Member States. The pilots sites will deploy and demonstrate the effect, benefit, value and scalability of GATEKEEPER solutions around reference use cases covering primary, secondary and terciary prevention in the Basque Country (Spain), Aragon (Spain), Attica and Central Greece (Greece), Cyprus (Cyprus), Lodz (Poland), Milton Keynes (UK), Puglia (Italy) and Saxony (Germany). The Basque Country pilot site is involved in the Reference Use Cases focused to "Lifestyle-related early detection". The intervention aims to encourage active and healthy ageing by the use of a self-managed mobile application, thereby to enhance independence, autonomy and improve the well-being of older people, promoting their physical, cognitive and mental activity and social participation. This quasi-experimental and longitudinal study is target to 10,000 older people and/or their caregivers from the Basque Country region. A multi-channel and community-based recruitment strategy at Basque regional level has been designed that involves 39 community-based organizations from the Basque Health Ecosystem.
Status | Recruiting |
Enrollment | 10000 |
Est. completion date | December 31, 2023 |
Est. primary completion date | December 31, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years and older |
Eligibility | PARTICIPANTS -Inclusion criteria - Subjects are eligible for the study if they are: - 65 years of age or older and/or their caregiver, family members and reference people - With stable internet access and at least one of the following devices to use the GATEKEEPER application: Smartphone or Tablet - They or their informal caregivers understand, read and talk the native language. PARTICIPANTS -Exclusion criteria Patients are not eligible for recruitment if: - Aged < 65 years - Do not have access to internet or at least one of the following devices to use the GATEKEEPER application: Smartphone or Tablet INFORMAL CAREGIVERS- Inclusion criteria The informal caregiver will be a person who provides occasional or regular support to the participant. Caregivers are eligible if: - The participant they take care of meet the inclusion criteria - They have stable internet access and at least one of the following devices to use the GATEKEEPER application: Smartphone or Tablet INFORMAL CAREGIVERS-Exclusion criteria Caregivers are not eligible if the user meets the exclusion criteria. PROFESSIONALS-Inclusion criteria Professionals are eligible if they have a direct connection with participants who meet the inclusion criteria and accept to participate. Professionals taking part in GATEKEEPER intervention should be: • open to the use of new technology. They should be willing to learn how to use technology to support users if needed. PROFESSIONALS-Exclusion criteria Professionals are not eligible if they do not care for users who meets the inclusion criteria or only care for patients who meet the exclusion criteria. |
Country | Name | City | State |
---|---|---|---|
Spain | Irati | Barakaldo | Bizkaia |
Lead Sponsor | Collaborator |
---|---|
Kronikgune | Basque Health Service |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in Quality of Life by EuroQoL-5D | EQ-5D is an instrument which evaluates the generic quality of life developed in Europe and widely used. The EQ-5D descriptive system is a preference-based HRQL measure with one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. | Change from baseline quality of life at 6 months | |
Primary | Get up from the chair 5 times test | The Get up from your chair 5 times test is aimed at measuring the participant's functionality. It assesses the muscular power of the lower limbs during the exercise of getting up and sitting down from the chair. | Change from baseline result of the test at 6 months | |
Secondary | App Usability Questionnaire MAUQ | MAUQ is a questionnaire that measures the usability of interactive medical mobile applications. It consists of 21 questions which are divided into three dimensions: the Ease of Use and Satisfaction dimension which covers items 1 to 8 and assesses the ease of use and user satisfaction of mHealth applications, the second dimension called System Information Structure which covers items 9 to 14 and refers to the information layout of the system and finally the third dimension Utility which contains the remaining items 15 to 21 and assesses the usefulness of the application. This questionnaire uses a seven-point seven-point Likert-type scale (1 = strongly disagree, 2 = disagree, 3 = somewhat disagree, 4 = neither disagree, 4 = neither disagree nor agree, 5 = somewhat agree, 6 = agree, and 7 = strongly disagree, 5 = somewhat agree, 6 = agree, and 7 = somewhat agree. 14 strongly agree) | Up to 6 months | |
Secondary | App usage by users | The metrics stored in the App server will allow to measure the usage of the app by users. Different metrics will be collected: number of app downloaded, number of registered users, number of active users, number of times the user has visit each module, the modules that received more visits, nº contents with more linkes. | Up to 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |